# Spotlight on Perfusion: Reshaping Oropharyngeal Squamous Cell Carcinoma Surgery

**Authors:** Fernando Dip, Guillermo Artero, Alberto Rancati, Javier I Ghiselli, Rene Aleman

PMC · DOI: 10.7759/cureus.87480 · 2025-07-07

## TL;DR

This paper discusses the use of fluorescence-guided surgery to improve the precision and safety of throat cancer surgery.

## Contribution

The paper presents a novel near-infrared fluorescence-guided surgery device applied in a complex OPSCC case.

## Key findings

- Fluorescence-guided surgery using indocyanine green enhances tumor visualization during resection.
- The technique allows for real-time tissue differentiation, reducing surgical complications.
- A successful case of radical OPSCC resection and reconstruction is demonstrated using the new device.

## Abstract

Oropharyngeal squamous cell carcinoma (OPSCC), commonly referred to as throat or tonsil cancer, is a type of head and neck malignancy arising from the base and posterior third of the tongue, tonsils, soft palate, and posterolateral pharyngeal walls. Standard treatment typically involves a single modality or a combination of surgery, radiotherapy, and/or chemotherapy. Despite favorable oncologic outcomes, chemoradiation is associated with considerable acute and long-term toxicities, including treatment-related mortality, debilitating dysphagia, fibrosis, severe xerostomia, and an increased risk of secondary malignancies. In this context, fluorescence-guided surgery (FGS) has emerged as a promising, minimally invasive intraoperative tool for OPSCC surgery. By leveraging indocyanine green (ICG), FGS offers enhanced visualization and real-time tissue differentiation, facilitating precise tumor resection and reducing the risk of surgical complications. This case presents an 83-year-old female patient who underwent radical OPSCC resection followed by complex reconstructive surgery utilizing a novel near-infrared FGS device.

## Linked entities

- **Chemicals:** indocyanine green (PubChem CID 5282412)
- **Diseases:** Oropharyngeal squamous cell carcinoma (MONDO:0044704), tonsil cancer (MONDO:0006998)

## Full-text entities

- **Diseases:** throat or tonsil cancer (MESH:D014067), toxicities (MESH:D064420), malignancies (MESH:D009369), xerostomia (MESH:D014987), fibrosis (MESH:D005355), dysphagia (MESH:D003680), OPSCC (MESH:D000077195), head and neck malignancy (MESH:D006258)
- **Chemicals:** ICG (MESH:D007208)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12329617/full.md

---
Source: https://tomesphere.com/paper/PMC12329617